Report #2831643

Received Mar 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 1.5 yrs
State: —
Recovered: Unknown
Vaccinated: Mar 5, 2025
Onset: Mar 5, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	2YS34	—

Symptoms (1)

Expired product administered

Symptom narrative

administration of Havrix expired dose to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 18-month-old female patient who received HAV (Havrix) (batch number 2YS34, expiry date 02-MAR-2025) for prophylaxis. On 05-MAR-2025, the patient received Havrix. On 05-MAR-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: administration of Havrix expired dose to a patient). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-MAR-2025 The medical assistant reported the administration of Havrix expired dose to a patient, which led to an expired vaccine used. The HCP (health care professional) requested guidance on this situation.